Concepedia

Scott A. Long

SA

Statistics

Publications

11

Citations

772

H-Index

11

Active since

1996

Affiliations

Pfizer (United States)(Current)

Scott A. Long is an author at Pfizer (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1996–2018

11

Publications

11

Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7 Inhibit Apoptosis and Maintain Cell Functionality

Dennis Lee, Scott A. Long, Jerry L. Adams et al. · Journal of Biological Chemistry · 2000 · 234 citations · Full text

, , +8

Potent and Selective Nonpeptide Inhibitors of Caspases 3 and 7

Dennis Lee, Scott A. Long, Jeffrey H. Murray et al. · Journal of Medicinal Chemistry · 2001 · 165 citations · Full text

, , +9

Discovery of (3<i>S</i>,3a<i>R</i>)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy

Marvin J. Meyers, Graciela B. Arhancet, Susan L. Hockerman et al. · Journal of Medicinal Chemistry · 2010 · 91 citations · Full text

, , +13

Chiral Organolithium Complexes:  The Structure of β-Lithiated β-Phenylcarboxamides and the Mechanism of Asymmetric Substitution in the Presence of (−)-Sparteine

Donald J. Gallagher, Hua Du, Scott A. Long et al. · Journal of the American Chemical Society · 1996 · 51 citations

, , +9

Benzothiophene inhibitors of MK2. Part 2: Improvements in kinase selectivity and cell potency

David R. Anderson, Marvin J. Meyers, Ravi G. Kurumbail et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 46 citations · Full text

, , +12

1–5 of 11